Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population

Sara Patrizi,Evelina Miele,Lorenza Falcone,Silvia Vallese,Sabrina Rossi,Sabina Barresi,Isabella Giovannoni,Lucia Pedace,Claudia Nardini,Ilaria Masier,Luana Abballe,Antonella Cacchione,Ida Russo,Angela Di Giannatale,Valentina Di Ruscio,Claudia Maria Salgado,Angela Mastronuzzi,Andrea Ciolfi,Marco Tartaglia,Giuseppe Maria Milano,Franco Locatelli,Rita Alaggio
DOI: https://doi.org/10.1186/s13148-023-01621-7
2024-01-06
Clinical Epigenetics
Abstract:Malignant peripheral nerve sheath tumors (MPNSTs) account for 3–10% of pediatric sarcomas, 50% of which occur in neurofibromatosis type 1 (NF1). Sporadic MPNSTs diagnosis may be challenging due to the absence of specific markers, apart from immunohistochemical H3K27me3 loss. DNA methylation (DNAm) profiling is a useful tool for brain and mesenchymal neoplasms categorization, and MPNSTs exhibit a specific DNAm signature. An MPNST-like group has recently been recognized, including pediatric tumors with retained H3K27me3 mark and clinical/histological features not yet well explored. This study aims to characterize the DNAm profile of pediatric/juvenile MPNSTs/MPNST-like entities and its diagnostic/prognostic relevance.
oncology,genetics & heredity
What problem does this paper attempt to address?